Evidence map›Paper›PMID 37189644›Full record

ArticleBiomedicines2023

The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis.

Susana Coimbra, Cristina Catarino, Maria Sameiro Faria, José Pedro L Nunes, Susana Rocha, Maria João Valente, Petronila Rocha-Pereira, Elsa Bronze-da-Rocha, Nuno Bettencourt, Ana Beco and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Susana CoimbraUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-8411-8038
Cristina CatarinoUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Maria Sameiro FariaUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
José Pedro L NunesFaculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Susana RochaUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-4196-2217
Maria João ValenteUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-6162-2426
Petronila Rocha-PereiraUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Elsa Bronze-da-RochaUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Nuno BettencourtFaculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Ana BecoHemodialysis Clinic Hospital Agostinho Ribeiro, 4610-106 Felgueiras, Portugal.
Sofia Homem de Melo MarquesHemodialysis Clinic Hospital Agostinho Ribeiro, 4610-106 Felgueiras, Portugal.
José Gerardo OliveiraHemodialysis Clinic of Porto (CHP), 4200-227 Porto, Portugal.
José MadureiraNefroServe, Hemodialysis Clinic of Barcelos, 4750-110 Barcelos, Portugal.
João Carlos FernandesNefroServe Hemodialysis Clinic of Viana do Castelo, 4900-281 Viana do Castelo, Portugal.
Vasco MirandaHemodialysis Clinic of Gondomar, 4420-086 Gondomar, Portugal.
Luís BeloUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Alice Santos-SilvaUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal.
Universidade do Porto · PTPolytechnic Institute of Viana do Castelo · PTUniversity of Beira Interior · PT

Funding

Fundação para a Ciência e Tecnologia UIDB/04378/2020
6 · The paper itself

Abstract

Left ventricular hypertrophy (LVH) is a common cardiovascular complication in end-stage kidney disease (ESKD) patients. We aimed at studying the association of LVH with adiponectin and leptin levels, cardiovascular stress/injury biomarkers and nutritional status in these patients. We evaluated the LV mass (LVM) and calculated the LVM index (LVMI) in 196 ESKD patients on dialysis; the levels of hemoglobin, calcium, phosphorus, parathyroid hormone, albumin, adiponectin, leptin, N-terminal pro B-type natriuretic peptide (NT-proBNP) and growth differentiation factor (GDF)-15 were analyzed. ESKD patients with LVH (

Indexed as

calciumGDF-15hemoglobinleft ventricular mass indexleptinNT-proBNP

Identifiers

PMID37189644
PMCPMC10135564
OpenAlexW4361213207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.